---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-216469"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2021-07-15T23:59:59+00:00"
generated_at: "2026-06-30T04:59:46.947859+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Catalyst Biosciences promotes Grant Blouse to CSO; CMO Howard Levy to retire Aug 15

## Summary
- Grant Blouse promoted to Chief Scientific Officer from SVP Translational Research; base salary $414,000 annually.
- Blouse eligible for annual performance-based bonus up to 40% of base salary.
- CMO Howard Levy to retire effective Aug 15, 2021; will join Clinical Advisory Board for hemophilia programs.
- Levy's retirement not due to any disagreement with the company or its management.

## SEC filing metadata
- accession: 0001193125-21-216469
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2021-07-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/0001193125-21-216469-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/d125524d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-216469
- JSON: https://secwatch.observer/filing/0001193125-21-216469.json
- Plain text: https://secwatch.observer/filing/0001193125-21-216469.txt

## Key facts
- Executive change
  Grant Blouse changed role as Chief Scientific Officer at GYRE THERAPEUTICS, INC..
  - Action: promoted
  - Role: Chief Scientific Officer
  source text: On July 14, 2021, Catalyst Biosciences, Inc. (the “Company”) announced that Grant Blouse has been promoted to Chief Scientific Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/0001193125-21-216469-index.htm
- Executive change
  Howard Levy retired as Chief Medical Officer at GYRE THERAPEUTICS, INC..
  - Action: retired
  - Role: Chief Medical Officer
  source text: On July 14, 2021, the Company announced that Howard Levy, the Company’s Chief Medical Officer, plans to retire from his position.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124105/000119312521216469/0001193125-21-216469-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.